4//SEC Filing
Combs Andrew 4
Accession 0001562180-25-002779
CIK 0001678660other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:40 PM ET
Size
5.2 KB
Accession
0001562180-25-002779
Insider Transaction Report
Form 4
Combs Andrew
Chief Chemistry Officer
Transactions
- Purchase
Common Stock
2025-03-25$0.69/sh+100,000$69,250→ 480,123 total
Footnotes (1)
- [F1]The reported total includes 2,500 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001825005
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:40 PM ET
- Size
- 5.2 KB